Publicly traded biotech company Absci lays off employees, citing ‘macro-economic conditions’

Vancouver, Wash.-based drug design and development company Absci laid off employees Tuesday, a little more than a year after going public.

“The macro-economic conditions of the last few months prompted us to engage in a comprehensive business analysis to focus the company on those activities that will create the greatest value,” said CEO and founder Sean McClain in a blog post. read more